Condition (MeSH)
Brucellosis
ClinicalTrials.gov lists 13 trials for Brucellosis or a narrower condition beneath it.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials per phase
13 of the 13 trials are tagged with Brucellosis itself; the rest are tagged with a narrower condition beneath it.
When did Brucellosis trials start? (8)
Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
Trials over time, by phase
- Not applicable
- Observational
Top of scale: 2
Trials registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table's notes). The table below lists the same counts, most recent years first.
| Year | Trials started |
|---|---|
| 2026 (partial year) | 2 |
| 2025 | 2 |
| 2024 | 1 |
| 2022 | 2 |
| 2021 | 2 |
| 2020 | 1 |
| 2019 | 2 |
| 2013 | 1 |
No forecast is made for this condition: it averages 1.4 trial starts a year over the five years to September, under the 5 a year the method needs.
Recruitment duration, a model prediction: none of the 13 trials evaluated at the 2026-10-09 snapshot is predicted and still running. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
What phase are Brucellosis trials in? (2)
Shown in this order: phase order.
Show the trials by phase as a table
| Phase | Trials |
|---|---|
| Not applicable | 5 |
| Observational | 8 |
How many Brucellosis trials are recruiting? (4)
Shown in this order: the order a trial moves through, from not yet recruiting to unknown.
| Status | Trials |
|---|---|
| Not yet recruiting | 3 |
| Recruiting | 2 |
| Completed | 7 |
| Unknown status | 1 |
Status as registered on ClinicalTrials.gov. Each trial is counted once.
Interventions as named in the registry (7)
Shown in this order: most trials first.
| Drug | Trials |
|---|---|
| Triple oral regimen (Doxycycline + Rifampicin + Levofloxacin) | 1 |
| Doxycycline + Moxifloxacin | 1 |
| Doxycycline + Levofloxacin | 1 |
| Doxycycline + Rifampicin | 1 |
| Antibiotics | 1 |
Showing 5 of 7 interventions.
These are the names sponsors entered on ClinicalTrials.gov that we have not matched to a single molecule. Some are drugs under a brand or code name; others are procedures, doses or arm labels.
Which publications cover Brucellosis? (12)
Shown in this order: major-topic papers first, then newest, then most linked to trials.
| Publication | Journal | Year | Major topic |
|---|---|---|---|
| Clinical Characteristics, Treatment, and Prognosis of Osteoarticular Brucellosis: A Retrospective Real-World Study in Shenyang, China, 2014-2019. | Foodborne pathogens and disease | 2025 | Yes |
| A mouse model of anemia of inflammation: complex pathogenesis with partial dependence on hepcidin. | Blood | 2014 | Yes |
| How human brucellosis incidence in urban Kampala can be reduced most efficiently? A stochastic risk assessment of informally-marketed milk. | PloS one | 2010 | Yes |
| Cognitive and emotional changes in neurobrucellosis. | The Journal of infection | 2006 | Yes |
| Brucellosis. | The New England journal of medicine | 2005 | Yes |
Showing 5 of 12 publications.
Prevalence (75)
Shown in this order: jurisdiction, then disease name. Orphanet observation for the mapped ORPHA concept; the mapping relation column says whether that concept is exactly this condition or broader or narrower.
| Orphanet disease | Type | Class | Geography | Jurisdiction | Mapping relation |
|---|---|---|---|---|---|
| Brucellosis | Annual incidence | <1 / 1 000 000 | United Kingdom | GB | Unspecified |
| Brucellosis | Annual incidence | <1 / 1 000 000 | United Kingdom | GB | Exact |
| Brucellosis | Annual incidence | <1 / 1 000 000 | United Kingdom | GB | Exact |
| Brucellosis | Annual incidence | 1-9 / 1 000 000 | Portugal | Not stated | Unspecified |
| Brucellosis | Annual incidence | <1 / 1 000 000 | Romania | Not stated | Exact |
Showing 5 of 75 prevalence observations.
Rare-disease identity (2)
Shown in this order: exact, broader, narrower, other.
| Orphanet disease | ORPHA code | Relation | Source |
|---|---|---|---|
| Brucellosis | 1304 | Exact | Orphadata Science knowledge files, Product 1 |
| Brucellosis | 1304 | Exact | Orphanet Rare Disease Ontology (ORDO) |
Not on this page
Not measured: delivery record.
Checked, with nothing recorded for this condition: lead sponsors, serious adverse events in this condition's trials, and sub-conditions in mesh.